TrialHaematologica2010

Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial.

Theo de Witte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.